These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 22874808)

  • 21. Incidence and duration of antidepressant-induced nausea: duloxetine compared with paroxetine and fluoxetine.
    Greist J; McNamara RK; Mallinckrodt CH; Rayamajhi JN; Raskin J
    Clin Ther; 2004 Sep; 26(9):1446-55. PubMed ID: 15531007
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Duloxetine in the treatment of major depressive disorder: comparisons of safety and tolerability in male and female patients.
    Stewart DE; Wohlreich MM; Mallinckrodt CH; Watkin JG; Kornstein SG
    J Affect Disord; 2006 Aug; 94(1-3):183-9. PubMed ID: 16780958
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Galactorrhea during duloxetine treatment: a case report.
    Korkmaz S; Kuloğlu M; Işık U; Sağlam S; Atmaca M
    Turk Psikiyatri Derg; 2011; 22(3):200-1. PubMed ID: 21870310
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Lymphocytic colitis associated with oxetorone consumption].
    Fathallah N; Chatti S; Azouz MM
    Gastroenterol Clin Biol; 2010 Feb; 34(2):154-5. PubMed ID: 20096517
    [No Abstract]   [Full Text] [Related]  

  • 25. Duloxetine 60 mg/day for the prevention of depressive recurrences: post hoc analyses from a recurrence prevention study.
    Kelin K; Berk M; Spann M; Sagman D; Raskin J; Walker D; Perahia D
    Int J Clin Pract; 2010 May; 64(6):719-26. PubMed ID: 20345508
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Generalized tonic-clonic seizure secondary to duloxetine poisoning: a short report with favorable out come.
    Pellicciari A; Balzarro B; Scaramelli A; Porcelli S; Serretti A; De Ronchi D
    Neurotoxicology; 2012 Mar; 33(2):189-90. PubMed ID: 22306002
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term duloxetine withdrawal syndrome and management in a depressed patient.
    Hou YC; Lai CH
    J Neuropsychiatry Clin Neurosci; 2014; 26(1):E4. PubMed ID: 24515685
    [No Abstract]   [Full Text] [Related]  

  • 28. Duloxetine 60 mg once daily in the treatment of milder major depressive disorder.
    Perahia DG; Kajdasz DK; Walker DJ; Raskin J; Tylee A
    Int J Clin Pract; 2006 May; 60(5):613-20. PubMed ID: 16700869
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Microscopic lymphocytic colitis due to duloxetine: Case report and review of the literature.
    Millán-Nohales C; Ordieres-Ortega L; García-Martínez R
    Gastroenterol Hepatol; 2021 Mar; 44(3):222-223. PubMed ID: 33039169
    [No Abstract]   [Full Text] [Related]  

  • 30. Safety and tolerability of duloxetine in the treatment of major depressive disorder: analysis of pooled data from eight placebo-controlled clinical trials.
    Hudson JI; Wohlreich MM; Kajdasz DK; Mallinckrodt CH; Watkin JG; Martynov OV
    Hum Psychopharmacol; 2005 Jul; 20(5):327-41. PubMed ID: 15912562
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Case report: fulminant hepatic failure involving duloxetine hydrochloride.
    Hanje AJ; Pell LJ; Votolato NA; Frankel WL; Kirkpatrick RB
    Clin Gastroenterol Hepatol; 2006 Jul; 4(7):912-7. PubMed ID: 16797245
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Duloxetine-related panic attacks.
    Sabljić V; Rakun R; Ružić K; Grahovac T
    Psychiatr Danub; 2011 Mar; 23(1):114-6. PubMed ID: 21448113
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Duloxetine versus escitalopram and placebo: an 8-month, double-blind trial in patients with major depressive disorder.
    Pigott TA; Prakash A; Arnold LM; Aaronson ST; Mallinckrodt CH; Wohlreich MM
    Curr Med Res Opin; 2007 Jun; 23(6):1303-18. PubMed ID: 17559729
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Duloxetine (Cymbalta) for diabetic neuropathic pain.
    Med Lett Drugs Ther; 2005 Aug 15-29; 47(1215-1216):67-8. PubMed ID: 16103866
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Lymphocytic colitis secondary to phlebotomic drug intake].
    Gonzalez J; Arribas J; Ramos J; Hernandez F; Page A; Herrero F
    Gastroenterol Hepatol; 2000; 23(6):313. PubMed ID: 15324631
    [No Abstract]   [Full Text] [Related]  

  • 36. [Stalevo-associated lymphocytic colitis].
    Lim C; Macaigne G; Boivin JF; Auriaul ML; Deplus R
    Gastroenterol Clin Biol; 2008; 32(8-9):698-9. PubMed ID: 18400439
    [No Abstract]   [Full Text] [Related]  

  • 37. [Lymphocytic colitis following administration of mianserine].
    Béchade D; Desramé J; Raynaud JJ; Coutant G; Algayres JP
    Rev Med Interne; 2006 Jan; 27(1):78-80. PubMed ID: 16260071
    [No Abstract]   [Full Text] [Related]  

  • 38. Safety and tolerability of duloxetine at 60 mg once daily in elderly patients with major depressive disorder.
    Raskin J; Wiltse CG; Dinkel JJ; Walker DJ; Desaiah D; Katona C
    J Clin Psychopharmacol; 2008 Feb; 28(1):32-8. PubMed ID: 18204338
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antidepressants and the relief of osteoarthritic pain - findings from a study examining adjunctive duloxetine.
    Citrome L; Weiss-Citrome A
    Int J Clin Pract; 2012 May; 66(5):431-3. PubMed ID: 22432949
    [No Abstract]   [Full Text] [Related]  

  • 40. A case report of transient but clinically relevant interaction between methadone and duloxetine: a reply to McCance-Katz et al.
    Vorspan F; Ksouda K; Bloch V; Laplanche JL; Peoc'h K; Hajj A; Scherrmann JM; Mouly S; Lépine JP
    Am J Addict; 2010; 19(5):458-9. PubMed ID: 20716309
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.